Cleared Traditional

K131040 - EXTAVIPRO STERICAN 30G

K131040 is an FDA 510(k) clearance for EXTAVIPRO STERICAN 30G, manufactured by B.Braun Melsungen AG. The device is a Class 2 General Hospital device with product code FMI cleared through the Traditional 510(k) pathway after a 91-day FDA review.

K131040 · B.Braun Melsungen AG · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2013
Decision
91d
Days
Class 2
Risk

K131040 is an FDA 510(k) clearance for the EXTAVIPRO STERICAN 30G. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by B.Braun Melsungen AG (Fredrichsdorf, DE). The FDA issued a Cleared decision on July 15, 2013 after a review of 91 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all B.Braun Melsungen AG devices

FDA 510(k) Submission Details - K131040

510(k) Number K131040 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 15, 2013
Decision Date July 15, 2013
Days to Decision 91 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
38d faster than avg
Panel avg: 129d · This submission: 91d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMI Device Classification - Class 2, Special Controls

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 455
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K131040.
K-PACK II NEEDLE - 27G X 3/4 THIN WALL
K132233 · Terumo Europe N.V. · Sep 2013
STERICAN CANNULA
K131842 · B.Braun Medical, Inc. · Aug 2013
BD PEN NEEDLE
K131358 · Becton, Dickinson & CO · Jul 2013
CLICKFINE AUTOPROTECT PEN NEEDLE
K131123 · Ypsomed AG · Jul 2013
CLICKFINE PEN NEEDLE
K131125 · Ypsomed AG · Jul 2013
FASTRESPONDER STERNAL INTRAOSSEOUS DEVICE
K130487 · Pyng Medical Corp. · Jun 2013